European Commission ponders best way forward for medtech vigilance
This article was originally published in RAJ Devices
Should Europe have a centralised database and data-processing network to support the central reporting of incidents by manufacturers? Or should EU reference laboratories specialising in the scientific and technical analysis of specific device types or technologies be created, to focus on particular areas and to support a network of national test laboratories, thereby bringing about the co-operation of market surveillance authorities?
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.